logo

Herpes vaccine tests underway by company that made COVID-19 vaccines

Ever since BioNTech and its occasional corporate partner Pfizer announced they had developed an mRNA vaccine for COVID-19, biotech researchers have salivated over the promise of using mRNA vaccines on other pathogens. That speaks to the promise of mRNA vaccines: unlike conventional vaccine platforms, mRNA vaccines can be much more easily modified to treat new viruses....

Originally posted on salon.com